B. Tokgoz Et Al. , "Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD," RENAL FAILURE , vol.24, no.3, pp.315-323, 2002
Tokgoz, B. Et Al. 2002. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD. RENAL FAILURE , vol.24, no.3 , 315-323.
Tokgoz, B., UTAŞ, C., DOĞUKAN, A., Oymak, O., & Kelestimur, F., (2002). Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD. RENAL FAILURE , vol.24, no.3, 315-323.
Tokgoz, BÜLENT Et Al. "Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD," RENAL FAILURE , vol.24, no.3, 315-323, 2002
Tokgoz, BÜLENT Et Al. "Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD." RENAL FAILURE , vol.24, no.3, pp.315-323, 2002
Tokgoz, B. Et Al. (2002) . "Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD." RENAL FAILURE , vol.24, no.3, pp.315-323.
@article{article, author={BÜLENT TOKGÖZ Et Al. }, title={Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD}, journal={RENAL FAILURE}, year=2002, pages={315-323} }